Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, T.
Right arrow Articles by Lobe, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, T.
Right arrow Articles by Lobe, C. G.
[Cancer Research 66, 1294-1301, February 1, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model

Thaddeus Allen1,3, Minke van Tuyl6, Pratibha Iyengar7, Serge Jothy4,8, Martin Post5,6, Ming-Sound Tsao4,7 and Corrinne G. Lobe1,2,3

1 Molecular and Cellular Biology Division, Sunnybrook and Women's College Health Science Centre; 2 Toronto-Sunnybrook Regional Cancer Centre; Departments of 3 Medical Biophysics, 4 Laboratory Medicine and Pathobiology, and 5 Physiology, University of Toronto; 6 Lung Biology Research Program, Hospital for Sick Children Research Institute; 7 Ontario Cancer Institute, University Health Network-Princess Margaret Hospital; and 8 St. Michael's Hospital, Toronto, Ontario, Canada

Requests for reprints: Corrinne G. Lobe, Molecular and Cellular Biology Division, Sunnybrook and Women's College Health Science Centre, S-236, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. Phone: 416-480-6100, ext. 3382; Fax: 416-480-5703; E-mail: corrinne.lobe{at}swri.on.ca.

Groucho proteins are transcriptional corepressors that are recruited to gene regulatory regions by numerous transcription factors. Long isoforms, such as Grg1, have all the domains of the prototype Drosophila Groucho. Short Groucho proteins, such as Grg5, have only the amino-terminal Q and G/P domains. We generated Grg1 and Grg5 transgenic mice and found that Grg1 overexpression induces lung adenocarcinoma, whereas Grg5 overexpression does not. Coexpression of Grg5 with Grg1 reduces tumor burden. Grg1 and Grg5 both diminish p53 protein levels; however, only Grg1 overexpression induces elevated levels of ErbB1 and ErbB2 receptor tyrosine kinases. The molecular and biological changes that accompany tumor progression in Grg1 transgenic mice closely reiterate events seen in human lung cancer. We also found that within a human lung tumor tissue array, a significant number of carcinomas overexpress Grg1/TLE1. Our data suggest that Grg1 overexpression contributes to malignancy in human lung cancers. (Cancer Res 2006; 66(3): 1294-301)




This article has been cited by other articles:


Home page
BloodHome page
F. Dayyani, J. Wang, J.-R. J. Yeh, E.-Y. Ahn, E. Tobey, D.-E. Zhang, I. D. Bernstein, R. T. Peterson, and D. A. Sweetser
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
Blood, April 15, 2008; 111(8): 4338 - 4347.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.